Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing and able to sign a consent form before any trial procedures begin
- You must be 18 years of age or older
- You have been confirmed through a tissue or cell sample test to have stage IIA to IIIC non-small cell lung cancer (a specific type and stage of lung cancer)
- You have at least one area of cancer that can be measured on a scan
- You have not previously received any treatment aimed at fighting the cancer throughout your body (such as chemotherapy or immunotherapy) for advanced disease
- Your blood, heart, lung, liver, kidney, and immune system are all functioning without serious problems
- You are generally active and able to carry out daily activities with little or no limitation (confirm with trial site)
- Your doctors expect you to live for more than 3 months
Who may not be able to join:
- You have had surgery to treat your lung cancer
- You have previously received chemotherapy or radiotherapy before surgery (neoadjuvant treatment)
- You have received a type of treatment called cellular therapy within the last year
- You have diabetes, asthma, autoimmune diseases, or other ongoing conditions that have been treated but are not well controlled
- You have taken part in another clinical trial involving an experimental vaccine, drug, or medical device within the last month
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18305185629
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the Progression-free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.